RAPT Therapeutics, Inc. — Director's Dealing 2021

Aug 26, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: RAPT Therapeutics, Inc. (RAPT)
CIK: 0001673772
Period of Report: 2021-08-23

Reporting Person: Robbins Wendye (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-08-23	Common Stock	P	500	$31.1144	Acquired	500	Indirect
2021-08-23	Common Stock	P	500	$31.5	Acquired	1000	Indirect
2021-08-23	Common Stock	P	250	$32.05	Acquired	1250	Indirect
2021-08-23	Common Stock	P	225	$31	Acquired	1475	Indirect
2021-08-24	Common Stock	P	500	$31	Acquired	1975	Indirect
2021-08-24	Common Stock	P	25	$30.81	Acquired	2000	Indirect

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	8400	Direct
Common Stock	1300	Indirect
Common Stock	305	Indirect